Total Funding
33
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 33 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
150291
ConforMIS develops personalized, patient-specific implants, and instrumentation for knee-related therapeutics.
Acquired by 
Restor3d
- Denise E. Pedulla: Chief Legal Officer and Corporate Secretary
- Phil Johnston: Board of DirectorsPast Role: University of Massachusetts Amherst, Member Board of Trustees, Chair, UMass Building Authority Board of Directors
Restor3d
About the Company
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which it refers to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy.
Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers.
